Controlled clinical trials in cerebrovascular disease. A misused tool.
Marshall
J
J
National Hospitals for Nervous Diseases, London, England.
D001241:Aspirin / Q000627:therapeutic use; D002548:Cerebral Revascularization; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin